KDM4C and breast cancer: Similar to the pattern of histone cleavage and CTSL activation, KDM4C inhibition or downregulation induced a more pronounced elevation of ROS in KDM4C-amplified basal breast cancer cell lines (Fig. 5f,g and Extended Data Fig. 9a).